cp-55,940 has been researched along with hu 210 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Blond, O; Briley, EM; Felder, CC; Joyce, KE; Lai, Y; Ma, AL; Mackie, K; Mansouri, J; Mitchell, RL | 1 |
| Abood, ME; Compton, DR; Martin, BR; Showalter, VM | 1 |
| Chavatte, P; Depreux, P; Farce, A; Goossens, JF; Hénichart, JP; Lambert, DM; Millet, R; Muccioli, GG; Poupaert, JH; Stern, E | 1 |
| Gynther, J; Järvinen, T; Lahtela-Kakkonen, M; Laitinen, JT; Nevalainen, T; Parkkari, T; Poso, A; Salo, OM; Savinainen, JR | 1 |
| Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Brust, P; Günther, R; Lueg, C; Schepmann, D; Wünsch, B | 1 |
| Aiello, F; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Lamponi, S; Ligresti, A; Luongo, L; Maione, S; Marini, P; Pertwee, RG | 1 |
| Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F | 1 |
| de Vries, H; Frehland, B; Heimann, D; Heitman, LH; Lueg, C; Schepmann, D; Wünsch, B | 1 |
| Aiello, F; Boccella, S; Brizzi, A; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Frosini, M; Gado, F; Ligresti, A; Luongo, L; Maione, S; Manera, C; Marini, P; Mugnaini, C; Pertwee, RG; Pessina, F | 1 |
1 review(s) available for cp-55,940 and hu 210
| Article | Year |
|---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
10 other study(ies) available for cp-55,940 and hu 210
| Article | Year |
|---|---|
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Amidohydrolases; Animals; Arachidonic Acids; Base Sequence; Binding, Competitive; Calcium; Calcium Channel Blockers; Cannabinoids; CHO Cells; Cricetinae; Endocannabinoids; Enzyme Activation; Humans; Intracellular Fluid; Ion Channels; Kinetics; Mice; Molecular Sequence Data; Phospholipases; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Transfection | 1995 |
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Topics: Animals; Binding, Competitive; Brain; Cannabinoids; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Cyclohexanols; Guanine Nucleotides; Humans; Ligands; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; Sodium; Structure-Activity Relationship; Transfection | 1996 |
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
Topics: Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2006 |
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
Topics: Animals; Cannabinoid Receptor Modulators; Cerebellum; GTP-Binding Proteins; In Vitro Techniques; Ligands; Male; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2006 |
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
Development of fluorinated CB(2) receptor agonists for PET studies.
Topics: Animals; Carbazoles; CHO Cells; Cricetulus; Halogenation; Humans; Ligands; Molecular Docking Simulation; Positron-Emission Tomography; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2013 |
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Topics: Analgesics; Animals; Calcium Channels; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Ligands; Male; Mice; Molecular Structure; Nerve Tissue Proteins; NIH 3T3 Cells; Nociception; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Structure-Activity Relationship; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2014 |
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid | 2016 |
Bioisosteric replacement of central 1,2,4-oxadiazole ring of high affinity CB
Topics: | 2017 |
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity.
Topics: Amides; Analgesics; Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Structure; Rats; Receptors, Cannabinoid; Resorcinols; Structure-Activity Relationship; TRPV Cation Channels | 2020 |